Static outliers for The Oaks Partnership

There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to explain. At OpenPrescribing we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support prescribers and organisations to audit and review prescribing.

This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator, for prescriptions dispensed between April 2021 and August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.

It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical method code is openly available on GitHub here.

The DataLab is keen to hear your feedback on the results. You can do this by completing the following survey or emailing us at ebmdatalab@phc.ox.ac.uk. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed feedback.

Prescribing where The Oaks Partnership is higher than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Chlohexidine gluconate (Emollient) 7 Emollients 90 0.08 0.00 0.00 43.07
Arnica montana 3 Rubefacients, topical NSAIDS, capsaicin and poultice 222 0.01 0.00 0.00 33.29
Tazarotene 1 Preparations for psoriasis 106 0.01 0.00 0.00 11.57
Vancomycin hydrochloride 3 Some other antibacterials 3 1.00 0.04 0.14 6.91
Other zinc preparations 2 Zinc 2 1.00 0.03 0.15 6.31

Prescribing where The Oaks Partnership is lower than most

BNF Chemical Chemical Items BNF Subparagraph Subparagraph Items Ratio Mean std Z_Score Plots
Finasteride 84 Male sex hormones and antagonists 165 0.51 0.82 0.12 -2.69
Levothyroxine sodium 2139 Thyroid hormones 2159 0.99 1.00 0.00 -2.63
Other emollient preparations 64 Emollients 90 0.71 0.89 0.07 -2.54
Doxazosin mesilate 584 Alpha-adrenoceptor blocking drugs 620 0.94 0.99 0.02 -2.46
Beclometasone dipropionate 462 Corticosteroids (respiratory) 1586 0.29 0.57 0.12 -2.34
Clenil Modulite 50micrograms/dose inhaler : 45
Clenil Modulite 100micrograms/dose inhaler : 198
Clenil Modulite 200micrograms/dose inhaler : 38
Fostair 100micrograms/dose / 6micrograms/dose inhaler : 78
Fostair 200micrograms/dose / 6micrograms/dose inhaler : 30
Beclometasone 200micrograms/dose inhaler CFC free : 2
Qvar 50 inhaler : 2
Beclometasone 200micrograms/dose dry powder inhaler : 1
Qvar 50 Autohaler : 1
Beclometasone 100micrograms/dose inhaler CFC free : 8
Beclometasone 100microg/Formoterol 6microg/dose inh CFCfree : 8
Qvar 100 Autohaler : 3
Fostair NEXThaler 200microg/dose / 6microg/dose dry pdr inh : 3
Beclometasone 50micrograms/dose inhaler CFC free : 12
Qvar 100 inhaler : 12
Clenil Modulite 250micrograms/dose inhaler : 6
Fostair NEXThaler 100microg/dose / 6microg/dose dry pdr inh : 10
Beclometasone 100mcg/dose breath actuated inhaler CFC free : 5